Tarceva: A Detailed Guide to Its Role in Cancer Treatment

Tarceva: A Detailed Guide to Its Role in Cancer Treatment

Tarceva, also known by its generic name Erlotinib, is a targeted therapy medication used to treat certain types of cancer, including non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the growth and spread of cancer cells. Tarceva is often prescribed when other treatments, such as chemotherapy, have not been effective.

The dosage of Tarceva is typically one tablet taken once daily, either on an empty stomach or at least one hour before or two hours after a meal. It’s important to take Tarceva exactly as prescribed by your doctor to ensure the best possible outcome. Regular monitoring and follow-up appointments are essential to track your progress and manage any side effects.

Common side effects of Tarceva may include skin rash, diarrhea, fatigue, or loss of appetite. These symptoms are usually manageable and may improve over time. However, more serious side effects, such as severe skin reactions, lung problems, or liver issues, require immediate medical attention.

Before starting Tarceva, inform your doctor about any medical conditions you have, especially liver disease or a history of stomach ulcers. Tarceva can interact with other medications, such as blood thinners or certain antibiotics, so it’s important to discuss your full medical history with your healthcare provider.

This guide offers a comprehensive overview of Tarceva, its role in cancer treatment, and how to use it safely. Always consult your doctor for personalized advice.

All the essential information about Tarceva can be found here: Tarceva - iMedix